Related Experiment Videos
Anaerobic infections and Clostridium difficile colitis emerging during antibacterial therapy
Abstract:
Almost all cases of Clostridium difficile-related pseudomembranous colitis are related to antimicrobial therapy. Virtually all antibacterial agents have been implicated, notable exceptions being vancomycin and parenterally administered aminoglycosides. The most prominent causes of colitis are ampicillin, clindamycin and various cephalosporins. In general, this complication is related to suppression of indigenous flora and overgrowth of C. difficile. In the case of ampicillin, however, C. difficile is always susceptible. Beta-lactamase production by elements of the bowel flora leads to destruction of ampicillin and subsequently to increased counts of C. difficile and colitis. Much less well-appreciated, and much less studied, is overgrowth and subsequent infection by other types of anaerobic bacteria. Superinfection by anaerobes may follow the use of "intestinal antiseptics" such as oral neomycin; indeed, that is the rationale for the current practice in the U.S. of combining erythromycin or tetracycline with the oral aminoglycoside. Superinfection with anaerobes may also follow systemic administration of various antimicrobial compounds. Such superinfections may involve any site in the body, although sepsis and intraabdominal infection have been noted most commonly; all major types of anaerobes have been involved. A wide variety of antimicrobial compounds has been implicated in predisposing to anaerobic infection.
Insights
Antibiotic use can lead to Clostridium difficile colitis by disrupting gut flora. Some antibiotics, like ampicillin, also promote C. difficile overgrowth through bacterial resistance mechanisms, increasing colitis risk.
Area of Science:
- Microbiology
- Gastroenterology
- Pharmacology
Background:
- Clostridium difficile-related pseudomembranous colitis is primarily linked to antimicrobial therapy.
- Most antibacterial agents can cause this condition, with vancomycin and parenteral aminoglycosides being exceptions.
- Ampicillin, clindamycin, and cephalosporins are frequently implicated in C. difficile colitis.
Purpose of the Study:
- To explore the mechanisms by which antimicrobial agents predispose to Clostridium difficile and other anaerobic bacterial infections.
- To highlight the less-studied phenomenon of anaerobic bacterial superinfections following antibiotic use.
Main Methods:
- Review of existing literature on antimicrobial-induced colitis and superinfections.
- Analysis of the role of indigenous flora suppression and bacterial resistance in C. difficile overgrowth.
- Examination of cases involving anaerobic bacterial superinfections.
Main Results:
- Antimicrobial therapy disrupts normal gut flora, allowing C. difficile overgrowth and colitis.
- Beta-lactamase production by gut bacteria can inactivate ampicillin, promoting C. difficile.
- Anaerobic bacterial superinfections, including sepsis and intraabdominal infections, can occur after various antimicrobial treatments.
Conclusions:
- Antimicrobial agents are a major risk factor for C. difficile colitis and anaerobic bacterial superinfections.
- Understanding these mechanisms is crucial for managing and preventing antibiotic-associated complications.
- Further research is needed on anaerobic superinfections following antimicrobial use.